Anti-VEGFR2-targeted immunoliposomes loaded with doxorubicin, a chemotherapeutic drug, reduced blood microvessel density promoting endothelial apoptosis and impairing tumor cell proliferation [172]. Here, KDR is linked to neoplasm.